Top of page
Main Content

Development of a Prognostic Blood Test

The test will be utilised to assist with prognosis, patient follow-up and assessment of the efficacy of adjuvant treatments. This research is aimed at characterisation and quantification of circulating melanoma cells and is of immense importance for clinicians and patients.


Researchers

Professor Mel Ziman
Cancer Council Professor of Clinical Cancer Research, Sir Charles Gairdner Hospital and The University of Western Australia, Professor Michael Millward
Director, Perth Melanoma Clinic, Associate Professor Robert Pearce
Private Practice, St John of God Hospital, Subiaco, Mr Mark Lee
Private Practice, St John of God Hospital, Subiaco, Dr Prasad Kumarasinghe
Ms Anna Reid
Mr Jamie Feeman
Sir Charles Gairdner Hospital, Dr Amanda Ireland
Ms Pauline Zaenker
Ms Cindy Jackson
Ms Dragana Klinac
Ms Tammy Esmaili

Skip to top of page